Stat3 Promotes Metastatic Progression of Prostate Cancer
- 30 June 2008
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 172 (6), 1717-1728
- https://doi.org/10.2353/ajpath.2008.071054
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3Clinical Cancer Research, 2006
- The metastatic cascade in prostate cancerSurgical Oncology, 2006
- RHO GTPASES: Biochemistry and BiologyAnnual Review of Cell and Developmental Biology, 2005
- RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in VivoJournal of Biological Chemistry, 2005
- Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factorsJournal of Clinical Pathology, 2005
- Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinaseThe Prostate, 2005
- Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cellsOncogene, 2004
- Expression patterns of potential therapeutic targets in prostate cancerInternational Journal of Cancer, 2004
- Combined Genome-Wide Scan for Prostate Cancer Susceptibility GenesJNCI Journal of the National Cancer Institute, 2004
- Increased Expression of the Interleukin-11 Receptor and Evidence of STAT3 Activation in Prostate CarcinomaThe American Journal of Pathology, 2001